Science & Nuclear Leaders Urge Pause on Apprenticeship Reforms

Jan 13, 2026 | News

Image Source: Cambridge_Spark from Pixabay
Written by: Contributor
On behalf of: Life Science Daily News

Leaders in life sciences and nuclear urge review of proposed changes

Leaders across the science sector have made an urgent call to government to reconsider potentially harmful reforms to the way apprenticeships are assessed.

Members of two leading employer bodies representing tens of thousands of workers across science-based industries – the Science Industry Partnership (SIP) and the Nuclear Industry Skills Partnership (NISP) – have written to the skills minister, Baroness Jacqui Smith, raising their concerns.

SIP represents companies in the life sciences and industrial science industries, while NISP’s membership includes companies of all sizes in civil and defence. Both sectors are critical to the UK’s economic growth.

Among the concerns raised is that shortening apprenticeships and making assessments ‘lighter touch’ will compromise learner competence and increase operational risk.

The employers also say reducing their involvement in designing the standards which underpin apprenticeships will lead to qualifications with less credibility and that won’t meet industry needs.

Life sciences, defence and advanced manufacturing are among the critical sectors of the economy which the government has prioritised for driving growth and greater prosperity around the country.

Chair of SIP, Alex Felthouse, said:

“The government’s commitment to making the UK a global life sciences superpower relies on a first-class workforce with the right knowledge, skills and behaviours.

“However, we’re concerned these reforms put workforce competence at risk – so we’re urging government to work with us in rethinking them and to understand what businesses of all sizes need to thrive.”

“Our industries have enormous potential to drive much-needed economic growth and the right workforce is absolutely fundamental to this. But these changes could undermine the integrity of technical education and jeopardise the UK’s ability to deliver on its clean energy and innovation commitments.

“Employers have the expertise and we believe government should make the most of that in reshaping the apprenticeship system to help deliver the workforce of the future.”

About Cogent Skills

The employer-led groups are supported by Cogent Skills, the leading skills body for the UK’s science and technology sectors.

For more information, visit www.cogentskills.com

    References: None

    Articles that may be of interest

    Weekly News Roundup | 2 November 2026

    Weekly News Roundup | 2 November 2026

    Life science news 2 November 2026: four approvals, three deals and a UK Budget investment package. Ferring has agreed to acquire Gameto in a deal worth up to $1.3825bn. The FDA granted accelerated approval to Voceryq for recurrent respiratory papillomatosis. The MHRA...

    read more
    Eppendorf and BioLabs Expand Collaboration to Munich

    Eppendorf and BioLabs Expand Collaboration to Munich

    The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies. It builds on existing partnerships at BioLabs sites across the US, Germany and France. HAMBURG and MUNICH, Germany, 21 October 2026...

    read more
    Weekly News Roundup | 26 October 2026

    Weekly News Roundup | 26 October 2026

    Life science news 26 October 2026: two major deals, three US approvals, two UK updates and a reverse merger. Roche signed an antibody-drug conjugate deal with Hansoh. Merck KGaA agreed to buy Silence Therapeutics for about $1.3bn. The FDA granted accelerated approval...

    read more

    Articles that may be of interest

    Weekly News Roundup | 2 November 2026

    Weekly News Roundup | 2 November 2026

    Life science news 2 November 2026: four approvals, three deals and a UK Budget investment package. Ferring has agreed to acquire Gameto in a deal worth up to $1.3825bn. The FDA granted accelerated approval to Voceryq for recurrent respiratory papillomatosis. The MHRA...

    read more
    Eppendorf and BioLabs Expand Collaboration to Munich

    Eppendorf and BioLabs Expand Collaboration to Munich

    The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies. It builds on existing partnerships at BioLabs sites across the US, Germany and France. HAMBURG and MUNICH, Germany, 21 October 2026...

    read more
    Weekly News Roundup | 26 October 2026

    Weekly News Roundup | 26 October 2026

    Life science news 26 October 2026: two major deals, three US approvals, two UK updates and a reverse merger. Roche signed an antibody-drug conjugate deal with Hansoh. Merck KGaA agreed to buy Silence Therapeutics for about $1.3bn. The FDA granted accelerated approval...

    read more